Altogether, our results suggest existence of distinct subsets of cancer cells which express CTIP2 and underscore the use of CTIP2 and BMI1 co-labeling to identify tumor initiating cancer stem cells (CSC). This evidence concerns the gene BMI1 and neoplasm.